CDNA CLONE HNEAA81 ENCODING HUMAN 7-TRANSMEMBRANE RECEPTOR

PROBLEM TO BE SOLVED: To obtain a newly identified polynucleotide useful for the treatment and diagnostic assay of e.g. infectious diseases, pain, cancer, neuropathy, by making the identified polynucleotide include a specific nucleotide sequence. SOLUTION: This isolated polynucleotide includes a nuc...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	HALSEY WENDY S, SATHE GANESH MADHUSUDAN
Format:	Patent
Sprache:	eng
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR COMPOSITIONS THEREOF CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES CULTURE MEDIA ENZYMOLOGY FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROCESSES OF PREPARING SUCH COMPOSITIONS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS TESTING VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	PROBLEM TO BE SOLVED: To obtain a newly identified polynucleotide useful for the treatment and diagnostic assay of e.g. infectious diseases, pain, cancer, neuropathy, by making the identified polynucleotide include a specific nucleotide sequence. SOLUTION: This isolated polynucleotide includes a nucleotide sequence >=97% identical over the whole length with a nucleotide sequence encoding HNEAA81 polypeptide of formula I and encoding a polypeptide having HNEAA 81 polypeptide activity or a nucleotide complementary to the above nucleotide. It is preferable that this isolated polynucleotide includes a nucleotide sequence contained in formula II, encoding HNEAA81 polypeptide of formula I, and HNEAA81 polypeptide is produced by culturing host cells having an expression system capable of producing HNEAA81 polypeptide.